Vericel Corp Contracts & Agreements

Vericel Corporation Deferred Compensation Plan (Filed With SEC on August 2, 2023)

Vericel Corporation 2022 Omnibus Incentive Plan Restricted Stock Unit Award (Deferred) Agreement for Non-Employee Directors (Filed With SEC on August 2, 2023)

Vericel Corporation Deferred Compensation Plan (Filed With SEC on May 5, 2023)

Eighth Amendment to the Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated May 15, 2022 (Filed With SEC on August 3, 2022)

Third Amendment to the Dispensing Agreement between AllCare Plus Pharmacy, Inc. and the Company, dated May 16, 2022 (Filed With SEC on August 3, 2022)

Form of New Hire Incentive Stock Option Agreement under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)

Form of Current Employee Incentive Stock Option Agreement under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)

Form of Restricted Stock Unit Award Agreement for Employees under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)

Form of Restricted Stock Unit Award Agreement for Non-employee Directors under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)

Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)

Lease Agreement, dated January 28, 2022, by and between the Company and NBD Property Owner 2, L.P (Filed With SEC on May 4, 2022)

Form of Current Employee Incentive Stock Option Agreement under the 2019 Omnibus Incentive Plan (amended February 15, 2022) (Filed With SEC on May 4, 2022)

Form of New Hire Incentive Stock Option Award Agreement under the 2019 Omnibus Incentive Plan (amended February 15, 2022) (Filed With SEC on May 4, 2022)

Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the 2019 Omnibus Incentive Plan (amended February 15, 2022) (Filed With SEC on May 4, 2022)

Vericel Corporation 2022 Omnibus Incentive Plan (Filed With SEC on April 29, 2022)

Amendment 2 to Shareholder Rights Agreement, dated as of February 11, 2021 (Filed With SEC on February 24, 2021)

Lease Agreement, dated October 21, 2020, by and between the Company and Up 64 Sidney Street, LLC, as amended (Filed With SEC on February 24, 2021)

Form of Amended and Restated Incentive Stock Option Agreement for Employees under the 2019 Omnibus Incentive Plan (Filed With SEC on February 24, 2021)

Form of Amended and Restated Incentive Stock Option Agreement for New Hires under the 2019 Omnibus Incentive Plan (Filed With SEC on February 24, 2021)

Form of Amended and Restated Non-Qualified Stock Option Agreement under the 2019 Omnibus Incentive Plan (Filed With SEC on February 24, 2021)

Form of Amended and Restated Restricted Stock Unit Award Agreement for Employees under the 2019 Omnibus Incentive Plan (Filed With SEC on February 24, 2021)

Form of Restricted Stock Unit Award Agreement for Non-employee (Filed With SEC on February 24, 2021)

Employment Agreement, dated (Filed With SEC on February 24, 2021)

Amendment No. 2 to Shareholder Rights Agreement, dated as of February 11, 2021, between the Company and Continental Stock Transfer & Trust Company, as Rights Agent (Filed With SEC on February 12, 2021)

Employment Agreement, dated January 21, 2021, by and between Vericel Corporation and Joseph Mara (Filed With SEC on January 25, 2021)

Vericel Corporation Amended and Restated 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2020)

Description of Capital Stock (Filed With SEC on February 25, 2020)

Sixth Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated April 18, 2019 (Filed With SEC on August 6, 2019)

First Amendment to Dispensing Agreement by and between AllCare Plus Pharmacy and the Company, dated May 1, 2019 (Filed With SEC on August 6, 2019)

Supply Agreement between MediWound, Ltd. and the Company, dated May 6, 2019 (Filed With SEC on August 6, 2019)

Amended and Restated Employment Agreement by and between Michael Halpin and the Company, dated September 14, 2017 (Filed With SEC on August 6, 2019)

First Amendment to Employment Agreement by and between Michael Halpin and the Company, dated June 3, 2019 (Filed With SEC on August 6, 2019)

License Agreement between MediWound, Ltd. and the Company, dated May 6, 2019 (Filed With SEC on August 6, 2019)

Vericel Corporation 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)

Form of Incentive Stock Option Agreement for Employees under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)

Form of Incentive Stock Option Agreement for New Hires under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)

Form of Non-Qualified Stock Option Agreement under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)

Form of Restricted Stock Unit Award Agreement for Employees under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)

Form of Restricted Stock Unit Award Agreement for non-employee directors under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)

Form of New Hire Incentive Stock Option Agreement under the 2017 Omnibus Incentive Plan (Filed With SEC on February 26, 2019)

Form of Incentive Stock Option Award Agreement under the 2017 Omnibus Incentive Plan (Filed With SEC on February 26, 2019)

Form of Non-Employee Director Award Agreement under the 2017 Omnibus Incentive Plan (Filed With SEC on February 26, 2019)

Form of Restricted Stock Unit Award Agreement under the 2017 Omnibus Incentive Plan (Filed With SEC on February 26, 2019)

Fourth Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and theCompany, dated July 25, 2018 (Filed With SEC on November 6, 2018)

Dispensing Agreement by and between AllCare Plus Pharmacy and the Company, dated July 26, 2018 (Filed With SEC on November 6, 2018)

Fifth Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and theCompany, dated October 18, 2018 (Filed With SEC on November 6, 2018)

Underwriting Agreement by and between Vericel Corporation and Leerink Partners LLC, as representative of the underwriters named therein, dated May 31, 2018 (Filed With SEC on June 1, 2018)

Amended and Restated ACI-Maix Supply Agreement, dated March 17, 2018, as amended, by and between the Company and Matricel GMBH, incorporated herein by reference (Filed With SEC on May 8, 2018)

Second Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated October 13, 2017 (Filed With SEC on March 5, 2018)

Third Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated November 14, 2017 (Filed With SEC on March 5, 2018)

Amended and Restated Non-employee Director Compensation Guidelines (Filed With SEC on March 5, 2018)

Amendment No. 3 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated October 9, 2017 (Filed With SEC on December 28, 2017)

Amendment No. 3 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated October 9, 2017 (Filed With SEC on December 28, 2017)

Amendment No. 4 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated November 9, 2017 (Filed With SEC on December 28, 2017)

Amendment No. 4 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated November 9, 2017 (Filed With SEC on December 28, 2017)

Amendment No. 5 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated December 5, 2017 (Filed With SEC on December 28, 2017)

Amendment No. 5 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated December 5, 2017 (Filed With SEC on December 28, 2017)

Warrant issued by the Company to ICT (Filed With SEC on December 28, 2017)

Third Loan Modification Agreement, dated as of December 6, 2017, by and between the Company, Agent and Lenders (Filed With SEC on December 8, 2017)

Form of Warrant issued by the Company to each of SVB and MidCap (Filed With SEC on December 8, 2017)

Amendment No. 1 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated August 3, 2017 (Filed With SEC on November 7, 2017)

Amendment No. 2 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated September 5, 2017 (Filed With SEC on November 7, 2017)

Amendment No. 1 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated August 3, 1017 (Filed With SEC on November 7, 2017)

Amendment No. 2 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated September 5, 2017 (Filed With SEC on November 7, 2017)

First Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated August 10, 2017 (Filed With SEC on November 7, 2017)

First Amendment to Executive Employment Agreement by and between Dominick C. Colangelo and the Company, dated September 14, 2017 (Filed With SEC on September 19, 2017)

Amended and Restated Employment Agreement by and between Daniel Orlando and the Company, dated September 14, 2017 (Filed With SEC on September 19, 2017)

Amended and Restated Employment Agreement by and between Gerard Michel and the Company, dated September 15, 2017 (Filed With SEC on September 19, 2017)

SECOND LOAN MODIFICATION AGREEMENT (Filed With SEC on June 2, 2017)

* * * * * (Filed With SEC on June 2, 2017)

DISTRIBUTION AGREEMENT (Filed With SEC on June 2, 2017)

FIFTH AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on June 2, 2017)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 15, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 30, 2016)

CONFIDENTIAL AND PROPRIETARY TO PPD (Filed With SEC on December 30, 2016)

FIRST LOAN MODIFICATION AGREEMENT (Filed With SEC on December 30, 2016)

6,200,000 Shares VERICEL CORPORATION Common Stock PURCHASE AGREEMENT (Filed With SEC on December 16, 2016)

DISTRIBUTION AND SERVICES AGREEMENT (Filed With SEC on November 25, 2016)

FOURTH AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on November 25, 2016)

THIRD AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on November 7, 2016)

VERICEL CORPORATION $25,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on October 11, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on September 14, 2016)

WARRANT TO PURCHASE STOCK (Filed With SEC on September 14, 2016)

AMENDED AND RESTATED CONTRACT MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on August 8, 2016)

FIRST AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on August 8, 2016)

SECOND AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on August 8, 2016)

SEVENTH AMENDMENT TO TRANSITION SERVICES AGREEMENT (Filed With SEC on August 8, 2016)

SERVICES AGREEMENT (Filed With SEC on May 10, 2016)

TRANSITION SERVICES AGREEMENT by and among GENZYME CORPORATION and AASTROM BIOSCIENCES,INC. Dated as of May30, 2014 TABLE OF CONTENTS (Filed With SEC on March 14, 2016)

TRANSITION SUPPLY AGREEMENT (Filed With SEC on March 14, 2016)

64 Sidney Street Cambridge, Massachusetts LANDLORD FC 64 SIDNEY, INC. TENANT GENZYME CORPORATION TABLE OF CONTENTS (Filed With SEC on March 14, 2016)

64 Sidney Street Cambridge, Massachusetts LANDLORD FC 64 SIDNEY, INC. TENANT GENZYME CORPORATION Table of Contents (Filed With SEC on March 14, 2016)

THIRD AMENDMENT TO A LEASE AGREEMENT BETWEEN DOMINOS FARMS OFFICE PARK, L.L.C. (LANDLORD) AND AASTROM BIOSCIENCES, INC. (TENANT) (Filed With SEC on March 14, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 9, 2016)

SECURITIES EXCHANGE AGREEMENT (Filed With SEC on December 18, 2015)

ACI-MAIX SUPPLY AGREEMENT between (Filed With SEC on November 13, 2015)

Nonemployee Director Compensation Guidelines (Filed With SEC on March 25, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on November 12, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on October 1, 2014)

UNDERWRITING AGREEMENT between AASTROM BIOSCIENCES, INC. and LADENBURG THALMANN & CO. INC. as Representative of the Several Underwriters (Filed With SEC on September 8, 2014)

Employment Offer Letter (Filed With SEC on June 4, 2014)

TRANSITION SERVICES AGREEMENT by and among GENZYME CORPORATION and AASTROM BIOSCIENCES, INC. Dated as of May 30, 2014 (Filed With SEC on June 2, 2014)

TRANSITION SUPPLY AGREEMENT (Filed With SEC on June 2, 2014)

Employment Offer Letter (Filed With SEC on April 1, 2014)

PURCHASE AGREEMENT (Filed With SEC on January 27, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 27, 2014)

CONSULTING SERVICES AGREEMENT (Filed With SEC on January 14, 2014)

AMENDMENT NO. 1 TO AT MARKET ISSUANCE SALES AGREEMENT (Filed With SEC on November 29, 2013)

UNDERWRITING AGREEMENT between AASTROM BIOSCIENCES, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on August 13, 2013)

[FORM OF WARRANT] AASTROM BIOSCIENCES, INC WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 13, 2013)

UNDERWRITING AGREEMENT between AASTROM BIOSCIENCES, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on August 12, 2013)

[FORM OF WARRANT] AASTROM BIOSCIENCES, INC WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 12, 2013)

UNDERWRITING AGREEMENT between AASTROM BIOSCIENCES, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on July 25, 2013)

[] Shares Aastrom Biosciences, Inc. Common Stock (no par value) Underwriting Agreement dated [], 2013 (Filed With SEC on May 13, 2013)

STANDARD LEASE SUMMARY (Filed With SEC on April 9, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on April 9, 2013)

MASTER SERVICES AGREEMENT (Filed With SEC on March 18, 2013)

RESIGNATION AGREEMENT (Filed With SEC on March 18, 2013)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2013)

Employment Offer Letter (Filed With SEC on December 12, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on October 26, 2012)

SECOND AMENDMENT TO AASTROM BIOSCIENCES, INC. 2009 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 7, 2012)

FORM OF WARRANT EXCHANGE AGREEMENT (Filed With SEC on June 27, 2012)

AMENDMENT NO. 1 TO SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on March 9, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 9, 2012)

AASTROM BIOSCIENCES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 9, 2012)

MASTER SERVICES AGREEMENT (Filed With SEC on November 22, 2011)

CONFIDENTIAL AND PROPRIETARY TO [ * * * ] (Filed With SEC on November 22, 2011)

AASTROM BIOSCIENCES, INC. (Filed With SEC on June 16, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on March 25, 2011)

AASTROM BIOSCIENCES, INC. SENIOR EXECUTIVE INCENTIVE BONUS PLAN (Filed With SEC on March 25, 2011)

FIRST AMENDMENT TO AASTROM BIOSCIENCES, INC. 2009 OMNIBUS INCENTIVE PLAN (Filed With SEC on March 25, 2011)

WARRANT AGREEMENT (Filed With SEC on December 16, 2010)

Underwriting Agreement between the Company and Stifel, Nicolaus & Company, Incorporated, as representative of the Underwriters, dated as of December 10, 2010 (Filed With SEC on December 10, 2010)

AASTROM BIOSCIENCES, INC. (Filed With SEC on August 31, 2010)

[COMPANY LETTERHEAD] EMPLOYMENT AGREEMENT (Filed With SEC on June 8, 2010)

CLASS A WARRANT AGREEMENT (Filed With SEC on January 27, 2010)

CLASS B WARRANT AGREEMENT (Filed With SEC on January 27, 2010)

Aastrom Biosciences, Inc. 46,154,000 Shares of Common Stock Class A Warrants to Purchase 34,615,500 Shares of Common Stock Class B Warrants to Purchase 23,077,000 Shares of Common... (Filed With SEC on January 15, 2010)

RESTATED ARTICLES OF INCORPORATION FOR USE BY DOMESTIC PROFIT CORPORATIONS (as amended in electronic format only as of December 14, 2009) (Filed With SEC on December 17, 2009)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on June 12, 2009)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 12, 2009)

TERMINATION AGREEMENT (Filed With SEC on May 27, 2009)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on October 29, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 29, 2008)

RESTATED ARTICLES OF INCORPORATION FOR USE BY DOMESTIC PROFIT CORPORATIONS (as restated in electronic format only as of October 17, 2008) (Filed With SEC on October 23, 2008)

BYLAWS OF AASTROM BIOSCIENCES, INC. (Filed With SEC on October 23, 2008)

CURRENT ASSETS (Filed With SEC on May 12, 2008)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2008)

ESCROW AGREEMENT (Filed With SEC on October 16, 2007)

AGREED AND ACCEPTED: Name of Investor: Name Title: Address: DWAC Number: AASTROM BIOSCIENCES, INC. By: Name: Title: (Filed With SEC on October 16, 2007)

Warrant No. [ ] Number of Shares: [ ] (subject to adjustment) Date of Issuance: October ___, 2007 Original Issue Date (as defined in subsection 2(a)): October ___, 2007 (Filed With SEC on October 16, 2007)

CURRENT ASSETS (Filed With SEC on February 9, 2007)

CURRENT ASSETS (Filed With SEC on February 9, 2006)

Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)

CURRENT ASSETS (Filed With SEC on November 9, 2004)

Local bone regeneration in fractures, spinal fusion and jaw bone reconstruction for dental implants (Filed With SEC on September 13, 2004)

Engagement Agreement dated March 19, 2004 by and between the Company and Jesup & Lamont Securities Corporation (Filed With SEC on April 2, 2004)

LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)

Common Stock Purchase Agreement with Fusion Capital Fund II, LLC dated October 20, 2002 (Filed With SEC on November 27, 2002)

LEGAL PROCEEDINGS (Filed With SEC on September 30, 2002)

EMPLOYMENT AGREEMENT (Filed With SEC on September 14, 2001)

Category

Industry

Companies

Contracts

Vericel Corp Contracts & Agreements